GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BUD:BAYER) » Definitions » Cyclically Adjusted PS Ratio

Bayer AG (BUD:BAYER) Cyclically Adjusted PS Ratio : 0.50 (As of May. 24, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Bayer AG Cyclically Adjusted PS Ratio?

As of today (2024-05-24), Bayer AG's current share price is Ft10796.00. Bayer AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was Ft21,696.00. Bayer AG's Cyclically Adjusted PS Ratio for today is 0.50.

The historical rank and industry rank for Bayer AG's Cyclically Adjusted PS Ratio or its related term are showing as below:

BUD:BAYER' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.48   Med: 1.49   Max: 3.18
Current: 0.5

During the past years, Bayer AG's highest Cyclically Adjusted PS Ratio was 3.18. The lowest was 0.48. And the median was 1.49.

BUD:BAYER's Cyclically Adjusted PS Ratio is ranked better than
85.89% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs BUD:BAYER: 0.50

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bayer AG's adjusted revenue per share data for the three months ended in Mar. 2024 was Ft5,447.435. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is Ft21,696.00 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bayer AG Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted PS Ratio Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.48 0.99 0.94 0.90 0.62

Bayer AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 0.92 0.83 0.62 0.52

Competitive Comparison of Bayer AG's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted PS Ratio falls into.



Bayer AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bayer AG's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=10796.00/21696
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bayer AG's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5447.435/125.0381*125.0381
=5,447.435

Current CPI (Mar. 2024) = 125.0381.

Bayer AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 5,998.167 99.543 7,534.457
201409 5,561.905 99.823 6,966.867
201412 5,765.026 99.543 7,241.602
201503 5,584.289 99.717 7,002.333
201506 5,795.459 100.417 7,216.461
201509 5,350.490 100.417 6,662.389
201512 5,312.679 99.717 6,661.752
201603 5,709.674 100.017 7,138.076
201606 5,750.791 100.717 7,139.504
201609 4,008.851 101.017 4,962.136
201612 3,920.263 101.217 4,842.889
201703 4,249.649 101.417 5,239.443
201706 3,956.338 102.117 4,844.374
201709 3,863.424 102.717 4,702.968
201712 4,108.932 102.617 5,006.700
201803 4,551.134 102.917 5,529.349
201806 4,326.461 104.017 5,200.793
201809 3,943.524 104.718 4,708.771
201812 4,297.022 104.217 5,155.487
201903 5,052.102 104.217 6,061.418
201906 4,410.387 105.718 5,216.411
201909 3,941.549 106.018 4,648.694
201912 4,348.846 105.818 5,138.762
202003 5,167.604 105.718 6,112.013
202006 4,122.205 106.618 4,834.396
202009 3,647.719 105.818 4,310.283
202012 4,427.053 105.518 5,246.047
202103 5,343.392 107.518 6,214.106
202106 4,761.189 108.486 5,487.631
202109 4,189.556 109.435 4,786.911
202112 4,573.905 110.384 5,181.140
202203 5,869.881 113.968 6,440.037
202206 4,933.632 115.760 5,329.041
202209 4,066.586 118.818 4,279.478
202212 4,628.209 119.345 4,848.992
202303 5,609.026 122.402 5,729.806
202306 4,356.406 123.140 4,423.542
202309 4,018.543 124.195 4,045.836
202312 4,709.690 123.773 4,757.832
202403 5,447.435 125.038 5,447.435

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bayer AG  (BUD:BAYER) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bayer AG Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (BUD:BAYER) Business Description

Industry
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (BUD:BAYER) Headlines

No Headlines